Despite a decline of more than 52% in Oracle Corp. (NYSE: ORCL) stock over the 12 months through September 15, 2026, Siti Panigrahi, a Wall Street analyst at Mizuho Securities, forecasts a strong recovery over the next 12 months.
Panigrahi reiterated an ‘Outperform’ rating for Oracle stock, according to a note sent to clients on Tuesday. He also maintained the firm’s 12-month price target for ORCL at $320.
With Oracle stock trading at $144.79 at the time of writing, Mizuho Securities suggests a potential 121.01% upside over the next 12 months. This bullish thesis is based on accelerating cloud infrastructure growth and strong execution.
Furthermore, Panigrahi demonstrated disciplined operational expenditures (OpEx), which successfully expanded its operating margins by around 35 basis points (bps) year-over-year (YoY). However, this firm urged investors to watch the company’s main risk in its net cash capital expenditures (CapEx) for financial year 2027 (FY27) not to exceed $70 billion.
Is Oracle a good stock to buy?
At the time of publication, 30 Wall Street analysts surveyed by TipRanks over the past 30 days have set an average 12-month price target for Oracle stock at $251.52. With an average rating of ‘Strong Buy’ these analysts suggest a possible 73.71% uptick.
The highest ORCL price forecast is $400, while the lowest 12-month target is $145. These analysts are betting that Oracle could benefit from its cloud computing and Artificial Intelligence (AI) infrastructure.
ORCL price performance
Over the past 12 months, ORCL’s price has capitulated by 52.08%, thereby reducing the company’s market capitalization to roughly $417.1 billion at the time of publication.
With ORCL’s price having established a strong support level near $138 year-to-date (YTD), these Wall Street analysts are predicting a rebound towards its former peak over the next 12 months.
Featured image via Shutterstock
